Whether retatrutide achieves FDA approval in 2025 or slips into 2026 is now one of the most closely watched questions in metabolic medicine, with implications not just for people seeking weight loss but for anyone interested in the broader architecture of healthspan and metabolic longevity
The sinus node, or the sinoatrial (SA) node, is your hearts natural pacemakera cluster of cells in the right atrium that generates electrical impulses that set the hearts rhythm and rate
The drug therefore non-covalently associates with endogenous albumin upon administration, which extends the plasma half-life of the peptide from a few hours to 7 days, enabling once-weekly injections 93,94
It is indicated for people who are obese and who have failed to lose enough weight with diet and exercise alone not for people who want to lose just a few pounds to create additional locks
Bottom line: MeAgain is better when the GLP-1 journey should be the product, not one feature inside a broader program